| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 1874218-36-6 | 3-Fluoro-alpha-[1-[(2-hydroxyethyl)amino]ethyl]benzenemethanol | C11H16FNO2 |
| 1874276-76-2 | 3-Amino-N-[3-(4-amino-4-methylpiperidin-1-yl)pyridin-2-yl]-6-[3-(trifluoromethyl)pyridin-2-yl]pyrazine-2-carboxamide | C22H23F3N8O |
| 1875153-79-9 | Mono-POM Methyl Adefovir | C15H24N5O6P |
| 1876467-74-1 | 2-[(3R)-3-Methyl-4-morpholinyl]-4-(1-methyl-1H-pyrazol-5-yl)-8-(1H-pyrazol-3-yl)-1,7-naphthyridine | C20H21N7O |
| 1878105-23-7 | N-XantPhos Pd G4 | C50H43N2O4P2PdS- |
| 1878109-35-3 | 2-[(2-Hydroxycyclopentyl)oxycarbonylamino]-3,3-dimethylbutanoic acid | C12H21NO5 |
| 1878111-20-6 | 2-butoxy-7-[[4-(1-pyrrolidinylmethyl)phenyl]methyl]-5H-pyrrolo[3,2-d]pyrimidin-4-amine | C22H29N5O |
| 1879009-96-7 | Methionine Impurity 1 | C12H22N2O4S2 |
| 1879903-65-7 | Rivaroxaban Oxo Amine Amide Impurity | C19H18ClN3O5S |
| 1882075-20-8 | (11bS)-4-Hydroxy-2,6-bis(2,3,4,5,6-pentafluorophenyl)-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 4-oxide | C32H11F10O4P |
| 1882095-50-2 | 2-(((3aR,4S,6R,6aS)-6-((6-(((3aS,4R,6S,6aS)-6-(2-Hydroxyethoxy)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)amino)-5-nitro-2-(propylthio)pyrimidin-4-yl)amino)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol | C27H43N5O10S |
| 1882095-51-3 | 2-(((3aS,4S,6R,6aS)-6-((5-amino-6-(((3aS,4R,6S,6aR)-6-(2-hydroxyethoxy)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)amino)-2-(propylthio)pyrimidin-4-yl)amino)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol | C27H45N5O8S |
| 1882873-21-3 | Lenvatinib Impurity 16 | C21H17ClN4O3 |
| 1883265-32-4 | 2-Chloro-4-(1-dibenzofuranyl)-6-phenyl-1,3,5-triazine | C21H12ClN3O |
| 1883265-36-8 | 2-([1,1'-Biphenyl]-3-yl)-4-chloro-6-(dibenzo[b,d]furan-1-yl)-1,3,5-triazine | C27H16ClN3O |
| 1883284-94-3 | 1-[(4-Fluorophenyl)methyl]-1H-indole-3-carboxylic acid 1-naphthalenyl ester | C26H18FNO2 |
| 1883299-62-4 | Brepocitinib | C18H21F2N7O |
| 1883377-30-7 | 8-[4-(2,2-Dimethylpropyl)-2-pyridinyl]-2-(methyl)-benzofuro[2,3-b]pyridine | C22H22N2O |
| 1883423-59-3 | [(2S)-2-(4-Chlorophenyl)-1-pyrrolidinyl](3-methyl-1H-pyrazolo[3,4-b]pyridin-5-yl)methanone | C18H17ClN4O |
| 1883429-22-8 | 4-(4-((Dimethylamino)methyl)-2,5-dimethoxyphenyl)-2-methyl-2,7-naphthyridin-1(2H)-one | C20H23N3O3 |
| 1883548-89-7 | NI 57 | C19H17N3O4S |
| 1883563-86-7 | Tenofovir Related Compound 8 | C22H40N7O6P |
| 1883595-37-6 | 5-(2-Fluorophenyl)-1-(3-pyridinylsulfonyl)-1H-pyrrole-3-carboxylic acid | C16H11FN2O4S |
| 1883595-38-7 | 5-(2-Fluorophenyl)-1H-pyrrole-3-carboxylic acid | C11H8FNO2 |
| 1883595-39-8 | 5-(2-Fluorophenyl)-N-methyl-1-(3-pyridinylsulfonyl)-1H-pyrrole-3-methanimine N-oxide | C17H14FN3O3S |
| 1883672-48-7 | Pabociclib Impurity B Hydrochloride | C29H38ClN7O4 |
| 1883681-10-4 | Azilsartan Impurity 21 | C29H26N4O7 |
| 1884139-61-0 | (Z)-Paricalcitol | C27H44O3 |
| 1884269-07-1 | Sacubitril-[d4] | C24H25D4NO5 |
| 1884279-18-8 | 4-(5-Methyl-3-phenyl-4-isoxazolyl)benzenesulfonic acid ethyl ester | C18H17NO4S |
| 1884576-18-4 | 2-Ethylbutyl (2S)-2-[[[(3aR,4R,6R,6aR)-4-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-4-cyano-2,2-dimethyl-6,6a-dihydro-3aH-furo[3,4-d][1,3]dioxol-6-yl]methoxy-phenoxyphosphoryl]amino]propanoate | C30H39N6O8P |
| 1884646-78-9 | CPI 410S | |
| 1884712-47-3 | CPI-637 | C22H22N6O |
| 1885094-62-1 | 5-(2-Fluorophenyl)-N,N-dimethyl-1-(3-pyridinylsulfonyl)-1H-pyrrole-3-methanamine | C18H18FN3O2S |
| 1886961-39-2 | 2-(3-Cyano-4-ethoxyphenyl)-4-methyl-5-thiazolecarboxylic acid | C14H12N2O3S |
| 1886994-07-5 | 3-Bromo-1H-pyrazole-5-carboxylic acid ethyl ester | C6H7BrN2O2 |
| 1887009-48-4 | (S)-3-(1-aminoethyl)-6-chloroquinolin-2(1H)-one hydrochloride | C11H12Cl2N2O |
| 1887009-51-9 | (R)-3-(1-aminoethyl)-6-chloroquinolin-2(1H)-one hydrochloride | C11H12Cl2N2O |
| 1887014-12-1 | Olutasidenib | C18H15ClN4O2 |
| 1887015-55-5 | 5-Fluoro-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile | C7H5FN2O |
| 1887057-05-7 | Docetaxel EP Impurity A | C41H55NO14 |
| 1887095-82-0 | 42-O-[2-[[1-[32-[4-Amino-3-(2-amino-5-benzoxazolyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-27-oxo-3,6,9,12,15,18,21,24-octaoxa-28-azadotriacont-1-yl]-1H-1,2,3-triazol-4-yl]methoxy]ethyl]rapamycin | C91H138N12O24 |
| 1887197-42-3 | 2-[(1S,2S)-1-Ethyl-2-(phenylmethoxy)propyl]hydrazinecarboxaldehyde ethanedioate (1:1) | C13H20N2O2.C2H2O4 |
| 1887742-42-8 | Adb-fubinaca metabolite M3 | C14H18N4O2 |
| 1888294-91-4 | 2,3,4,5-Tetrahydro-1-[2-methyl-4-(3-methyl-1H-pyrazol-1-yl)benzoyl]-5-oxo-1H-1-benzazepine-4-carboxylic acid ethyl ester | C25H25N3O4 |
| 1888419-06-4 | 6-[2-(Trifluoromethyl)-5-pyrimidinyl]-2-pyridinamine | C10H7F3N4 |
| 1888438-11-6 | 9-([1,1'-Biphenyl]-4-yl)-9'-(triphenylen-2-yl)-9H,9'H-3,3'-bicarbazole | C54H34N2 |
| 1888438-12-7 | 9-[1,1'-Biphenyl]-3-YL-9'-(2-triphenylenyl)-3,3'-BI-9H-carbazole | C54H34N2 |
| 1888902-20-2 | 4-Chloro-7-isoquinolinol | C9H6ClNO |
| 1889279-16-6 | A-485 | C25H24F4N4O5 |